Introduction
Detection of biological information using magnetoresistance (MR) sensors based on multilayered giant MR (GMR), or exchange biased GMR spin valves, operated by the magnetic field produced by magnetic nanoparticle sensor agents has been paid considerable attention in biomedical sensor technologies (Baselt et al., 1998; Tondra et al., 2000; Rife et al., 2003; Graham et al., 2004) . The main reason for this interest is that MR based biosensors provide technical advantages such as high sensitivity, relatively fast and low-volume assay, and easy manipulation of the magnetic sensor agents under the externally applied magnetic field gradients (Graham et al., 2002; Lagae et al., 2002) . These advantages lead to improved sensing performance, stimulating the development of functional in-vitro GMR based biosensors to obtain biological information and diagnose diseases more accurately in healthcare (Megen & Prins, 2005) . However, all the developed GMR biosensors so far were mostly focused on counting or indentifying multiple biomolecules such as a DNA counter and a bead array counter rather than single molecular detection (SMD) (Baselt et al., 1998; Miller et al., 2001; Graham et al., 2003; Li & Wang, 2003; Schepper et al., 2004; Wang et al., 2005; Shen et al., 2005) . The main physical reason for this technical limitation is that the magnetic susceptibility of a single superparamagnetic nanoparticle sensor agent (SPNSA), which can be easily manipulated on the sensor surface without any serious agglomeration and easily retrieve magnetic stray field, is too small to generate a large enough field for acheiving a reasonably high SNR (Singal-to-Noise Ratio). Although superparamagentic microbeads have been attempted to obtain a larger stray field for higher SNR for SMD (Graham et al., 2002; Wirix-Speetiens et al., 2006) , these agents were also revealed to have a technical drawback that they can not maintain one to one ratio between the microbead and the biomolecules due to a big mismatch in size. Hence, to develop more powerful in-vitro GMR bisoensor system for SMD, ferrimagentic nanoparticle (FN) sensor agents, which have a high remnant magentization expecting to producing a sufficient stray field for a higher SNR, and a high chemical stability as well as a high biocompatibility with living cells or biological entities, are currently considered as a feasible sensor agent to label the biomolecules. However, the applications of FN to a GMR biosensor agent has been limited for the past few years by a 164 techical challenge relevant to a possible particle agglomeration while they are introducing into the microchannel. Fortunetely, as a new functional microfluidic channel with micromagnet, which can allow for effectively manipulating the FNs to flow into the channel one by one, has been recently developed (Lagae et al., 2002; Ramaden et al., 2006; Latham et al., 2007) , the interests to apply a single FN sensor agent to an in-vitro GMR biosensor for SMD are dramtically increased in a molecular diagnostic biosensor system. In this chapter, the physical characteristics of an in-vitro GMR biosensor with an immoblized single FNSA is mainly discussed to provide crucial information how to optimize its strucure for SMD. In chapter 2, the sensing performance of an in-vitro GMR biosensor with an immobilized FNSA or SPNSA is numerically analyzed based on the "Stoner-Wolfarth model" to evaluate which GMR biosensor system is more suitable for SMD. In chapter 3, the optimization of sensor geometry considering the spatial magentic field interaction between the FNSA and the FL as well as the physical correlation between the "effective sesning area" and SNR is introduced to successfully design an in-vitro GMR biosensor enabling to show maximized SNR for SMD. Finally, chapter 4 discusses the newly desgined sensoror structure of an in-vitro GMR biosensor with a specially designed magnetic shield layer (MSL) to explore its technical effectiveness for the diagnostic biosensor applications based on SMD.
An in-vitro GMR biosensor with an immobilized single FNSA or SPNSA for SMD
To confirm which sensor system is more promising for SMD, the sensing performance of an in-vitro GMR biosensor with an immobilized FNSA or SPNSA should be first clarified. Four physical sensing parameters: (1) the relative MR change (δR) relevant to the magnetization angle difference between the free layer (FL) (sensing layer) and the pinned layer in GMR spin-valves, (2) the interaction factor (IF) describing the magnetic spatial interaction between the FL and the nanoparticle sensor agent, (3) the distance between the single immobilized FNSA or SPNSA and the FL, and (4) the practically allowable sensor size considering the physical limit of current sensor fabrication technology, are mainly considered for the comparison of sensing performance. The numerical analysis is based on the "Stoner-Wolfarth model" describing that the magentizations of the FL in the GMR biosensors are coherently rotated under a globally applied magentic field with twodimensional field components, which are homogeneous across the entire FL.
Physical model of spatial field distribution on an in-vitro GMR biosensor
The sensing mechanism of a GMR biosensor with an immobilized single FNSA or SPNA is illustrated in Fig. 1-(a) . The sensor agents are captured on the FL surface of GMR biosensor through a bio-recognition process and the resistance of the GMR sensor is accordingly changed by the stray field produced from the magnetic nanoparticles. As shown in Fig. 1 , the critical geometry parameters considered for the numerical calculation include the spacing between the SA and the sensor surface (h), and the geometry of FL, e.g. length (L), width (W), and thickness (t). Figure 1 -(b) describes the magnetization configuration of FL in the GMR biosensor and the magnetic spatial interaction between the SA and the FL. The magnetization of pinned layer (PL) is exchange biased to the negative transverse direction (-y) and the easy axis (EA) of the FL is along the longitudinal direction (+x) due to shape anisotropy and crystalline anisotropy. To minimize the geometrically-induced magnetostatic coupling www.intechopen.com 
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between the FL and the orthogonally coupled PL, the PL is considered as the "synthetic antiferromagnetic (AFM) layer", e.g. FM/non-magnetic/FM structure. The magnetization of FNSA is aligned in the positive transverse direction (+y) and the SPNSA is magnetized toward the positive transverse direction (+y) by the excitation field (+y) for comparison with the FNSA. In order to establish a physical model for the stray field induced by the magnetic nanoparticles, the single magnetic nanoparticle with spherical shape is assumed to be uniformly magnetized and has an effective dipole magnetic moment (m). The field intensity, H(H ≅ B in cgs unit) at a distance r can be expressed by equation (1) (Besse et al., 2002) .
The spatial distributions of the stray field induced by the magnetic nanoparticle on the FL of GMR biosensor are numerically calculated by considering the both longitudinal and transverse magnetic field components of an ideal dipole, as illustrated in Fig. 1 -(b). Fig. 1 . A schematic diagram of an in-vitro GMR biosensor with a single nanoparticle sensor agent for SMD (a) the molecular recognition process on the GMR biosensor surface, (b) the magnetic spatial interaction between the magnetic nanoparticle agents and the FL of GMR biosensor. All the field components generated from the bias field, H b , the excitation field, H t and the magnetic nanoparticles are illustrated on the FL sensor surface, and (c) a schematic diagram of magnetization configuration of a single magnetic nanoparticle and its variation due to the magnetic dipole interaction caused by the x-component of FL magnetization to the FNSA or the SPNSA.
According to the "Stoner-Wolfarth model", the magnetization direction of the FL (FL is in a single domain state as the sensor size is in submicron range in this model) is determined by the minimization of the total free energy as shown in equation (3). Hence, the total free energy with respect to θ ( Fig. 1-(c) ) is minimized. Our method is to set up a discrete array of θ. The range of this array is from 0 to 2π and the step size is 0.00001. With such small step size, the range of θ can be considered as a continuous range. By substituting the array into equation (3), the minimized energy and the corresponding θ can be obtained using a simple algorithm. The next step is to use the following equation (5) to calculate the magnetoresistance (MR) ratio based on the magnetization (spin) configuration of GMR biosensor where the magnetization direction of PL is exchange biased to a fixed direction (-y).
Where f θ and p θ are the angles of the FL, and the PL with respect to EA, respectively;
is the MR ratio of the GMR biosensor when the FL and PL is antiparallel with each other, which is also the maximum MR ratio for a GMR biosensor. To evaluate the sensing performance, the relative MR change, δR, is needed to be defined by equation (6). (6), the θ f,without is the angle between FL magnetization and EA when no sensor agent is on the sensor surface and the θ f,with is the angle between FL magnetization and EA when the sensor agent is on the sensor surface. For FNSA, the θ f,without is zero, thus δR can be written by
For SPNSA, the θ f,without is not zero due to the excitation field (see Fig. 1 -(b)) and thus the δR can be rewritten by
, where, θ d is the angle difference before and after the SPNSA captured on the sensor surface (dθ = θ f,without -θ f,with ). The fringe field from the FL of GMR biosensors is also considered to affect the magnetic properties of nanoparticle sensor agent in both magnetization direction and magnetic moment due to the magnetic dipole interaction between the FL and the nanoparticles (see Fig. 1-(b) ). Accordingly, the effect of fringe field from the FL on the δR is included in this model to precisely interpret the sensing performance. To find out how many percentages the FL fringe field would influence on the magnetic moment of the magnetic nanoparticles, the interaction factor (IF) defined as
is employed, where ' m is the magnetic moment considering the effect of the FL fringe field, m is the original magnetic moment and β is the angle difference between the original magnetization of sensor agent and the rotated magnetization due to the fringe field from FL as shown in Fig. 1-(c) . In this model, the FNSA is considered as a CoFe 2 O 4 nanoparticle. It has a remnant magnetization of 22 emu/g and a diameter of 26 nm (see Fig. 2 -(a) and (b) (3) can be simplified by equation (7),
Due to the fringe field from the FL of GMR biosensor ( H Δ ), the induced magnetic moment of the CoFe 2 O 4 nanoparticle becomes
, where f χ is considered as constant because the fringe field is relatively small. In addition, by considering the single domain state of CoFe 2 O 4 nanoparticle agent, the magnetization direction of the CoFe 2 O 4 nanoparticle can be calculated using the "Stoner-Wolfarth model" as below: and the total free energy can be correspondingly re-written by equation (9).
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As the χ value is constant and there is no magnetic anisotropy energy under no excitation field, the IF for the superparamagnetic CoFe 2 O 4 nanoparticle sensor agent can be simplified as 
Comparison of sensing output performance
Based on the physical model developed in section 2.1, the sensing output performance of an in-vitro GMR biosensor with a single immobilized FNSA or SPNSA is calculated and compared. Figure 3 shows the dependence of sensor width at the fixed sensor geometry (sensor aspect ratio) on the δR and the IF of the in-vitro GMR biosensors. The sensor width, W, of the GMR biosensor is changed from 10 to 80 nm at the different aspect ratio (L : W) changed from 3 : 1 to 10 : 1. The purpose of changing the sensor aspect ratio is to explore the effects of vortex magnetization on the surface of FL due to the geometrically-induced demagnetizing factor (Girgis et al., 2000) . The H b , and the h are fixed at a 50 Oe, and a 30 nm, resepctively for precise comparison. The CoFe 2 O 4 FNSA, and SPNSA has a mean particle size of 26 nm and 7 nm, resepctively. The δR and its variation due to the change of W is numerically analyzed by considering both the "effective sensing area", which is defined as the area formed on the FL surface whose magnetic spins can be coherently www.intechopen.com rotated by the stray magnetic field induced by the sensor agent, and the development of "inactive sensing area", which is not responded by the stray field, due to the increase of IF induced by the geometrically-increased magnetic anisotropy of FL. As shown in Fig. 3 , the in-vitro GMR biosensors with an immobilized single FNSA or SPNSA exhibit the same physical characteristics that the δR is abruptly decreased above the maximized value obtained at the optimized sensor width, W op , and that the IF is almost squarely increased, by increasing the W as well as the aspect ratio. This is supposed to be due to the increase of "inactive sensing area" and the magnetic anisotropy of FL induced by the increased sensor size proportional to the W. However, it is clearly noted that the absolute δR and IF values of the in-vitro GMR biosensor with a FNSA are much larger than those with a SPNSA. As can be clearly seen in Fig. 3-(a) and (c), the δR obtained from the invitro GMR biosensor with an aspect ratio of 3: 1 (75 nm (L) × 25 nm (W op )) and an immobilized FNSA is a 2.72 %, while the δR for the in-vitro GMR biosensor with a SPNSA, which has the same aspect ratio (45 nm (L) × 15 nm (W op )), is a 0.013 %. In addition, the variation of IF values depending on the W of the in-vitro GMR biosensor with a FNSA is negligibly small compared to those with a SPNSA as shown in Fig. 3-(b) and (d). The practically allowable sensor size based on the physical limit of current sensor fabrication technology, especially nanoelectronics technology, is another physical parameter to be considered in evaluating the sensing performance. Considering the patterning limit of EBL (Electron Beam Lithography) technique (> 50 nm) and the geometrically-induced demagnetizing factor of FL directly relevant to the sensor aspect ratio and the IF, the minimum sensor size can be determined in the range between 150 nm (L) × 50 nm (W) and 250 (nm) × 50 nm (W). However, as verified in Fig. 3-(a) and (c), the δR values obtained from these sizes of in-vitro GMR biosensor with a SPNSA are too small to be considered for a real biosensor application. According to the numerically analyzed sensing performance summarized in Fig. 3 , it is clearly demonstrated that an in-vitro GMR biosensor with an immobilized single CoFe 2 O 4 FNSA is more suitable for SMD due to its higher δR, less IF dependence, and practically allowable sensor size. The large remnant magnetization of single CoFe 2 O 4 FNSA allowing to produce a sufficiently large stray field and to maintain extremly small variation of IF is the main physical reason for the technical promise of GMR biosensor with an immobilized single FNSA for SMD.
Optimizing the sensor geometry of an in-vitro GMR biosensor with an immobilized FNSA for SMD
In this chapter, the detailed spatial magnetic field interactions between the single CoFe 2 O 4 FNSA and the FL of an in-vitro GMR biosensor is numerically analyzed to predict the optimized sensor geometry that maximizes the sensng perfromance for SMD prior to fabrication. In order to more accurately analyze the spatial magentic field interactions on the FL surface, the longitudinal and the transverse components of the stray field produced by the FNSA are considered. The optimized sensor geometry at a given remnant magentic moment of the FNSA is predicted by evaluating the "effective sensing area". The optimized sensor geometry is expressed in terms of the effective distance (δ), which includes the radius, a, of FNSA, the length of biological entities (especially, DNA including probe), membrane thickness, and the passivation layer, as well as the critical sensor length (Lee et al., 2007) . By considering only the logitudinal field compoent of the stray field produced by the immobilized single CoFe 2 O 4 FNSA, B x on the surface of FL along the x and y axis from equation (2) is simplified by equation (11) (Schepper et al., 2006) . 
171
The calculated magnetic field distribution and the two geometrically critical parameters, which are essential to determine the optimized sensor geometry, are also denoted in Fig. 4-(a) . The geometrical parameters of the in-vitro GMR biosensor with an immobilized single FNSA are first determined by considering the longitudinal component of the stray field. The effective magnetization, β, is defined as the ratio of the total magnetization of the CoFe 2 O 4 FNSA to the longitudinal field component of the stray field,
. The δ is defined as a h + = δ . The geomtrical parameters, the l c , and the w c for achieving the optimized sensor geometry, which maximize the sensor output performance, are dependent on β and δ. These geometrical parameters, which determine the "effective sensing area", 
The numerically analyzed magnetic field distribution on the surface of the FL finally obtained by equation (13) clearly demonstrates that the optimized geometrical parameters, l c , and w c are directly relevant to δ and sw β . In order to more accurately predict the optimized sensor geometry based on the "effective sensing area, c c w l × ", the numerical calculation is extended to two dimensional field component, both longitudinal and transverse field components, on the FL surface. The "Stoner-Wolfarth model" (or the "asteroid curve model") is employed for the detailed calculation (Hirota et al., 2002) .
Optimizing the sensor geometry considering the one dimensional (longitudinal) field component
As described in the analytical model developed in section 3.1, the optimization of sensor geometry with an immobilized CoFe 2 O 4 FNSA is based on the determination of l c , and w c by considering the longitudinal field component of B x , and B y , on the FL surface. Figure 5 shows the contour diagrams of the magnetic field intensity and its distributions, B x , and B y on the FL surface as a function of δ (for δ = 0.5, 1.0, and 2.0 μm). As can be seen in Figs. 5-(a), 5-(c), and 5-(e), the maximum B x is rapidly decreased from 691.2 to 10.8 G by increasing δ from 0.5 to 2.0 μm. As shown in Fig. 4-(b) , the in-vitro GMR biosensor considered in this model is operated at magnetic field intensity in the range from 12 G (B sw ) to 176 G (B DL ). Considering these the magnetic characteristics of GMR biosensor, the shaded region observed at δ = 0.5 μm due to the large field intensity (Fig. 5-(a) ) and all the regions shown in Fig. 5 -(e) do not contribute to the sensor operation. This indicates that the l c and the w c for the optimized sensor geometry based on equation (12) should be determined at δ c < 0.79 μm, which corresponds to the sensor operating condition of Fig. 5 clearly demonstrates that the geometrical and systematic design parameters (δ, l c , and w c ) of the in-vitro GMR biosensor for producing a highly stable sensing performance can be precisely predicted prior to fabrication if the remnant magnetization of the single CoFe 2 O 4 FNSA and the GMR characteristics of the sensor are known.
Optimizing the sensor geometry considering the longitudinal and transverse field components
Dependence of δ on the transverse component, B y , is also estimated to confirm its physical contribution to the optimization of in-vitro GMR biosensor geometry. , and 5-(e), the B y has a strong dependence on δ. However, the distribution of B y is completely different from B x . The distribution of B x on the FL surface shows an ellipsoidal shape with the major axis along the y-axis, while B y exhibits a distribution that has a maximum and minimum field intensity of
≈ at the position of (±δ, ∓ δ). The numerical comparison between B x and B y depending on δ suggests that both components of the stray field should be simultaneously www.intechopen.com considered for a more accurate prediction of the sensor geometry. Accordingly, the "StonerWolfarth model":
, is employed to accurately analyze the spatial magnetic field distribution and intensity on the FL surface. Even though the "StonerWolfarth model" assumes that the FL magnetizations are coherently rotated by the stray field and are homogneous across the entire FL surface, this model is considerably useful in interpreting the physical behavior of the in-vitro GMR biosensor under a highly localized magnetic dipole field from the immobilized single CoFe 2 O 4 FNSA. Figure 6 shows the magentic field distribution and intesity considering both the logitudinal and transverse field components with different effective distances: δ = 0.5, 1.0, and 2.0 μm. Unlike the ellipsoidal shape of the "effective sensing area" shown in Fig. 5 , the coherently rotated magnetization of the FL induced by two-dimensional magnetic field components shows a more complicated and extended "effective sensing area" due to the contribution of the transverse field component. Figure 7 shows the optimized sensor geometry (white line) and the "effective sensing area" (bright gray region) calculated by considering the one-dimensional Fig. 7-(a) ) and the two-dimensional components ( Fig. 7-(b) ) based on the "Stoner-Wolfarth model". Although the numerical values of optimized geometrical parameters determined at the effective distance of δ = 0.79 μm are the same as l c = 1.12 μm, and w c = 3.52 μm, the "effective sensing area" directly relevant to the sensing output performance is completely different. As can be seen in Fig. 7-(b) , the "effective sensing area" is extended due to the transverse field component. This correspondingly results in enhancing the output signal of the in-vitro GMR biosensor. However, as can be also seen in Fig. 7-(b) , an undetectable area in the vicinity of center of the optimized sensing area is developed due to the spatial magnetic field interaction. Making a GMR biosensor with a larger exchange bias field and introducing a specially designed sensor structure with a high permeability magnetic shield layer are suggested as an effective solution for the undesirable technical problem. 
Demonstration of sensing performance of the in-vitro GMR biosensors with optimized sensor geometry
The sensing performance of an in-vitro GMR biosensor with an immobilized CoFe 2 O 4 ferrimagentic nanobead SA geomtrically optimized by the analytical model developed in chapter 3.1 is demontrated to confirm its practical effectiveness. The CoFe 2 O 4 nanobead with a mean raius, a, of 925 nm synthesized by using a modified sol-gel mehtod is considered as a ferrimagentic nanobead SA. The optimized sensor geomtry of the in-vitro GMR biosesnor based on the equations (11) ~ (13) as well as considering a 925 nm of mean nanobead size is calcuated to determine the "effective sensing area, c c w l × ". The sensing output performance of the optimized GMR biosensors is evaluated as a function of sensor length, l, at the fixed w c by controlling the size of CoFe 2 O 4 nanobead SA, which is systematically varied in the range of a = 925 nm ± 20.5 % as shown in Fig. 8-(a) . The controlled nanobead size leads to changing the l at the fixed w c due to the variation of stray field intensity caused by the change of effective distance. The GMR biosensor used for this demosntration has a strucutre of Si/Ta (5) GMR biosensor structure and its GMR behaviour for the before and after patterning, and for the hard axis response are shown in Figs. 8(b) , and (c), respectively. As can be seen in Fig. 8-(a) , the magnetization of FL is orthogonally coupled to the pinned layer, and the stray field produced by the single CoFe 2 O 4 n a n o b e a d S A i s a p p l i e d t o t h e h a r d a x i s o f F L magnetization for the detection of output sensing signal. On the basis of the numerical analysis, the intensity of stray field produced by the CoFe 2 O 4 nanobead SA with a radius of 750 (-20.5 %, negative standard deviation), 925 (mean nano bead size), and 1150 nm (+20.5 %, positive standard deviation) is calculated by considering the experimentally obtained M r values to determine the l c . The calculated maximum field intensity is a 67.8, 116.5, and 177.1 Oe (G), respectively and the l c is revealed to be a 0.85, 1.08, and 1.31 μm, respectively at the fixed w c = 5 μm. Figure 9 shows the detected output signal obtained from the in-vitro GMR biosensor shown in Fig. 8-(b) . The detected signal is captured by using an oscilloscope. As can be clearly seen in Fig. 9-(a) , when a DC magnet with a constant field of 103 Oe (G) is brought proximity to the GMR biosensor, an output signal of V out = 6.13 mV (V output = 613 mV after 100 times amplication using a 741 OP-AMP) is successfully achieved. This is attributed to the MR change of the GMR biosensor, ΔR/R 0 = 2.2 %, which is exactly equal to the maximum MR ratio obtained along the hard-axis of the www.intechopen.com patternd GMR biosensor shown in Fig. 8-(c) . At a 103 Oe (G) of field intensity, the "effective sensing area", c c w l × induced by the DC magnetic field intensity is larger than the patterned sensor geomtry of l = 1 μm, and w = 5 μm. This indicates that all the FL magnetizations are fully rotated by the applied DC magnetic field resulting in exhibiting the maximum MR ratio of 2.2 %. In contrast, the output signals obtained from the in-vitro GMR biosensors activated by the CoFe 2 O 4 nanobead SAs show a strong dependence on the size of nanobead SA. As can be seen in Figs. 9-(b) , (c), and (d), the output voltage and the ΔV out /V of the GMR biosensor activated by the CoFe 2 O 4 nanobead SA with a size of 750, 925, and 1150 nm are V out = 6.07 mV (ΔV out /V = 1.2 %), V out = 6.12 mV (ΔV out /V = 2.0 %), and V out = 6.10 mV (ΔV out /V = 1.7 %), respectively. Even though the non-uniformity and the position dependent stray field intensity produced by the nanobead SA can be considered to be partially influenced on the variation of output sensing signal, the observed sensing signal depending on the size of nanobead SA is primarily interpreted in terms of two physical parameters: (a) the change of stray field intensity relevant to the switching field, and (b) the "inactive sensing area" as well as the development of "undetectable sensing area". As can be confirmed from the calcualtion results, the 0.85 μm of l c determined by the 750 nm size of nanobead SA at the fixed w c = 5 μm is smaller than the geometry of patterned GMR biosensor, l = 1 μm and w = 5 μm, that results in the reduction of MR ratio due to the "inactive sensing area". In addition, the reduced stray field intensity due to the decrease of nanobead size leads to the reduction of switching field that results in a lower output sensing signal as shown in Fig. 8-(c) . The slight decrease of output sensing signal obtained from the GMR biosensor with an 1150 nm size nanobead SA is thought to be due to the development of "undetectable sensing area" as shown in Fig. 7-(b) . The large stray field intensity, around 177.1 Oe (G), obtained from the large size of nanobead SA is comparable to the exchange bias field of the patterned GMR biosensor. This induces the partial magnetic reversal of pinned layer resulting in a slight MR degradation. Furthermore, the spatial magnetic field interaction due to the large stray field intensity causes to form an undesirable "undetectable sensing area" at the central region of FL surface of the patterned GMR biosensor that leads to the reduction of MR ratio as well as the output sensing signal.
Effects of a specially designed magnetic shield layer (MSL) on the sensing performance of an in-vitro GMR biosensor with an immobilized single FNSA for SMD
As previously discussed, the in-vitro GMR biosensor with an immobilized single CoFe 2 O 4 FNSA is suitable for SMD. However, accoridng to the numerical analysis on the spatial field interaction of the stray field, which is produced by a single FNSA, on the FL surface, the field distribution is found to be so complicated and non-uniform that it can not be easily interpreted. In particular, the creation of "undershoot field regions", which are formed at both edges of the maximum field intensity regions as well as the central regions of FL surface resulted from the spatial magnetic field interaction, is revealed as the most severe problem to induce the reduction of output sensing signal and the sensing stability of the invitro GMR biosensor. Thus, a new sensor structure, which can solve this technical challenge, is urgently required in a molecular based diagnostic GMR biosensor system for achieving more stable SMD. In this chapter, a new structure of in-vitro GMR biosensor with a specially designed magnetic shield layer (MSL) is introduced and discussed based on the numerically analyzed calculation results to explore its effectiveness for the improvement of sensing performance as well as the sensing stability. The effects of MSL thickness including magnetic permeability of MSL, and gap width of MSL on the change of "undershoot field" as well as the "stray field intensity" are primarily discussed to demonstrate the physical contribution of MSL to the sensing performance of the in-vitro GMR biosensor considering for SMD. Figure 10 -(a) shows a schematic diagram of an in-vitro GMR biosensor with a specially designed MSL. As shown in Fig. 10-(a) , the in-vitro GMR biosensor has a single CoFe 2 O 4 FNSA immobilized on the FL surface with a distanace of h μm, which is defined as the distacne between the FNSA and the FL surface of the GMR bionsensor. Accoridng to the physical model nuemrically developed in chapter 3.1 (Schepper et al., 2006) , the h can be expressed as equation (14), In this numerical calculation, an IrMn based exchange biased GMR spin-valve device is considered as a sensing element. Thus, to achieve a stable sensing performance, the maximum field intensity produced by the single FNSA should be adjusted to be lower than the exchange bias field of the GMR biosensor. Considering this sensor operating condition, B DL is determined based on the experimentally obtained exchange bias field from the patterned GMR biosensor. (14), a radius of 250 nm size CoFe 2 O 4 FNSA, an 176 G of exchange bias field, and a 0.48 μm of h are considered. As can be seen in Fig. 10-(a) , the calcualted h value includes FL/passivation layer (40 nm)/MSL (0 ~ 300 nm)/Al 2 O 3 functional membrane (140 nm; including a length of biological entities such as ten sequence of DNA: 34 nm). The Al 2 O 3 functional membrane layer in this sensor structure is used for both maintaing the h depending on the variation of MSL thickness and immobilizing the FNSA using a membrane probe. The high magnetic permeability of materials such as supermalloy and permally are considered as a MSL in this structure. Figure 10 -(b) shows a longitudinal field component (x direction) of stray field intesity on the FL surface without (solid line) and with (dashed line) MSL. The distribution of magentic field intensity shown in Fig. 10-(b) is calcualted as a function of distance from the center point of FNSA to the edge of GMR biosensor along the x direction. In addition, B max , B U1 , B U2 , and l eff are denoted as a maximum magentic field intensity, an undershoot field, an outer undershoot field, and an effective detectable length, which is the region enabled to be reversed by the stray field, respectively.
Designing of in-vitro GMR biosensor with magnetic shield layer (MSL)
(a) (b) (c) (d)
Effects of magnetic shield layer (MSL) on the sensing performance of in-vitro GMR biosensor for SMD
The MSL has a basic geometry of 300 nm thickness, a permeability of supermalloy (5.2 × 10 5 ), 1.2 μm gap width, and 8 μm length. To explore the effects of MSL on the sensing performance, the physical parameters of the MSL including its thickness, its gap width, and its permeability are changed from the basic structure. Figure 11 shows the dependence of MSL thickness on the sensing performance compared in terms of the physical sensing parameters such as B U1 , B max , l eff , and B U2 . As can be seen in Fig. 11-(a) , the undesirable "undershoot field region", B U1 , is dramatically reduced when the MSL has a 1 nm of thickness. By further increasing its thickness, B U1 is sharply decreased and then it is completely removed above t MSL = 100 nm. This indicates that the MSL needs to have a critical thickness to build up a close magnetic flux between the FNSA and the MSLs allowing for a distinct magnetic shielding effect. Figure 11 -(b) shows the dependence of MSL thickness on the change of B max . When the MSL has a 10 nm of thickness and above, the B max is decreased down to 158 G and then it saturates at 153 G by further increasing the MSL thickness above 100 nm. This numerical result along with the increase of l eff shown in Fig.  11 -(c) indicates that the effects of MSL on the improvement of sensing performance of the invitro GMR biosensor are quite prominent. The reduction of B max from 188 G (above B DL ) to 155 G (below the exchange bias field degradation point) and the increase of l c of the sensing area due to the MSL shielding effects allow the dramatic increase of "effective sensing area" on the FL surface that leads to the increase of sensing output signal of the patterned GMR biosensor. However, as can be seen in Fig. 11-(d) , the magnetic dipole field induced in the MSL due to its high magnetic moment generates another undesirable small "undershoot field", B U2 at the vicinity of the MSL edges. Even though its numerical value is small below 
12 G, it should be carefully controlled when the MSL is used for especially multi-array sensor architecture. The effects of MSL permeability on the sensing performance is not discussed in details in this chapter as all the physical sensing parameters have the same dependence on the permeability of MSL. However, the numerical calculation results obtained from the GMR biosensor with geometry of a 300 nm MSL thickness, a 1.2 μm of gap width, and a 8 μm of MSL length demonstrates that the MSL with magnetic permeability of at least 100 shows obvious shielding effects. Figure 12 shows the dependence of MSL gap width, which is changed from 0.2 to 2.0 μm, on the sensing performance of an in-vitro GMR biosensor with an immobilized CoFe 2 O 4 FNSA. As shown in Fig. 12-(a) , the B max is dramatically increased from 150 G to 260 G, which is beyond the sensing limit, B DL , by decreasing the gap width from 0.8 to 0.2 μm. The dramatic increase of magnetic field intensity at the gap width below 0.8 μm is mainly thought to be attributed to the increase of fringe field produced from the gap between two MSLs (This is quite similar to the "fringe field" produced by the head gap from the writer in magnetic recording technology) (Bertram, 1994) . The high permeability of two MSLs, which are closely faced each others with small gap, can produce a strong "deep gap bubble field" due to a high magnetic flux density. This leads to increasing the "fringe field" on the surface of MSL gap that would be diverged into the FL surface resulting in the increase of magnetic field intensity on the FL (sensing layer) surface. As shown in Figs. 12-(b) and 12-(c), the B U1 and the l eff are also strongly influenced by the MSL gap width. The B U1 is obviously re-developed when the MSL gap width is increased above 1.4 μm. Moreover, l eff is sharply decreased when the MSL gap width is increased above 1.2 μm. The serious degradation of sensing performance relevant to the dramatic reduction of "effective sensing area" on the sensor surface due to both the re-development of "undershoot field region" and the reduction of critical length, l c , are mainly attributed to the reduction of shield gap flux density, which is inversely proportional to the MSL gap width. However, considering that the l c (~1.56 μm), which is numerically determined based on the same geometry and configuration of in-vitro GMR biosensor system, is found to be much larger than that without MSL (~1.12 μm), it can be readily understood that shielding effects of MSL on the improvement of sensing performance is quite significant. In summary, it is numerically demonstrated that the MSL is effective to improve the output sensing performance of an in-vitro GMR biosensor with an immobilized FNSA, because it can successfully remove an undesirable "undershoot field region" and enhance the "effective sensing area" due to the increase of l c . This indicates that an in-vitro GMR biosensor with a specially designed MSL structure can be considered as a promising sensor structure for SMD due to its achievable high sensing signal and stability.
Conclusion
The physical sensing characteristics of an in-vitro GMR biosensor with an immobilized single FNSA have been introduced and discussed to explore its feasibility to a single molecular based disease diagnostic biosensor system. According to the theoretically and experimentally analyzed results, the in-vitro GMR biosensor with a FNSA was revealed to be more suitable for SMD than that with a SPNSA due to its higher relative MR, less interaction factor dependence, and practically allowable sensor size. In addition, the analytical models developed in this chapter allowed to readily predicting the optimized sensor geometry of an in-vitro GMR biosensor with a FNSA prior to fabrication if the physical parameters of the FNSA are provided. In particular, the in-vitro GMR biosensor with a specially designed magnetic shield layer (MSL) was demonstrated to be able to effectively control the undesirable "undershoot sensing region" as well as the "undetectable sensing area" on the FL surface. These promising sensing characteristics improved by the newly designed sensor structure allow for achieving both maximized output sensing signal and higher sensor stability that lead to accelerating the more practical applications to the SMD based diagnostic biosensor system.
